GE HealthCare Science Chief Taha Kass-Hout Resigns

The company's chief science and technology officer will leave his post effective December 31, 2026.

Updated on Nov. 5, 2026 in Biotech

Bold vector editorial illustration of a single medical scanning gantry standing alone in an empty clinical room, rendered in cream and slate with a coral accent. — GE HealthCare's chief science and technology officer Taha Kass-Hout resigned on November 4, 2026, with his departure effective December 31, 2026. AI Illustration. Upload story photo >

Taha Kass-Hout, Chief Science and Technology Officer at GE HealthCare Technologies Inc., notified the company of his resignation on November 4, 2026. His last day with the company will be December 31, 2026.

Why it matters

The departure of a company's top science and technology executive is disclosed to shareholders because it affects leadership of the company's technology and research direction. The disclosure was made in a required regulatory filing with the Securities and Exchange Commission.

The disclosure is a Form 8-K filing under Item 5.02, the SEC requirement covering officer departures, signed by General Counsel Frank R. Jimenez on November 5, 2026. The filing gives a notice date of November 4, 2026 and a final working day of December 31, 2026, but it does not name a replacement or explain the reason for leaving.

The players

GE HealthCare Technologies Inc.

GE HealthCare is a medical technology company spun off from General Electric, headquartered in Chicago and listed on the Nasdaq under the ticker GEHC, that makes imaging, ultrasound and diagnostic equipment.

Taha Kass-Hout

Taha Kass-Hout is a physician and technology executive who served as chief science and technology officer at GE HealthCare, overseeing the company's scientific and technology strategy.

The details

Kass-Hout held the Chief Science and Technology Officer role at GE HealthCare Technologies Inc., a Delaware corporation headquartered at 500 W. Monroe Street in Chicago. The company disclosed the departure in a Form 8-K filing that is required when a senior officer leaves.

November 4, 2026: Kass-Hout notifies GE HealthCare of his resignation.
November 5, 2026: The Form 8-K disclosing the resignation is filed.
December 31, 2026: Kass-Hout's last day at the company.

Big Picture

Departures of senior officers at publicly traded companies are reported under the SEC's Form 8-K Item 5.02 requirement, which is the disclosure rule this filing follows. Kass-Hout's exit is one such routine corporate-governance disclosure rather than a change in company direction, based on what the filing states.

For shareholders and investors, the filing confirms a scheduled leadership change at the end of the calendar year that may matter for long-term research priorities. The filing does not describe any change to products or services that consumers or patients would notice directly.

The takeaway

Senior officer changes are disclosed on a fixed timeline, so the eight-week gap between notice and departure gives the company time to plan a transition. Readers following GE HealthCare should watch for a named successor in a future filing.